Diagnostic Ultrasound System (Nuewa A20W); Diagnostic Ultrasound System (Nuewa A20); Diagnostic Ultrasound System (Nuewa A20 Exp); Diagnostic Ultrasound System (Nuewa A20 Elite); Diagnostic Ultrasound System (Nuewa A20Q); Diagnostic Ultrasound System (Nuewa A MV); Diagnostic Ultrasound System (Nuewa A Elite); Diagnostic Ultrasound System (Nuewa A MS); Diagnostic Ultrasound System (Nuewa A20 Premium); Diagnostic Ultrasound System (Nuewa A20 Plus); Diagnostic Ultrasound System (Nuewa A18
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Decision date Oct 16, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-10-16 for K261585, a traditional 510(k) submitted 05/13/2026 by Shenzhen Mindray Bio-Medical Electronics Co., Ltd. of Shenzhen, CN. The listed device name covers multiple Diagnostic Ultrasound System models under the Nuewa A20 and Nuewa A families, including A20W, A20, A20 Exp, A20 Elite, A20Q, A MV, A Elite, A MS, A20 Premium, A20 Plus and A18. The classification name is System, Imaging, Pulsed Doppler, Ultrasonic, under regulation 892.1550, product code IYN, with subsequent codes ITX and IYO.
The review panel and medical specialty are Radiology; the submission was not reviewed by a third party, is not a combination product, and no Predetermined Change Control Plan was authorized. SESE means the submission was cleared as substantially equivalent, not granted PMA approval. The source does not describe the specific component, software or design change at issue, nor any indications for use, so those details remain unknown here and would require the underlying 510(k) documents.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- Oct 16, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261585
- Regulatory pathway
- 510(k) premarket notification
- Product code
- IYN
- Decision code
- SESE
- Decision date
- Oct 16, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, Imaging, Pulsed Doppler, Ultrasonic.
- Product code
- IYN
- FDA device class
- 2
FDA decision timeline
K261585 received
Application receipt date recorded by FDA.
K261585 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code IYN
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | 510(k) clearance | Oct 8, 2026 | FDA | |
| Samsung Medison Co., Ltd. | 510(k) clearance | Oct 8, 2026 | FDA | |
| GE Medical Systems Ultrasound and Primary care Diagnostics, LLC | 510(k) clearance | Oct 2, 2026 | FDA | |
| Philips Ultrasound, LLC | 510(k) clearance | Sep 25, 2026 | FDA | |
| Samsung Medison Co., Ltd. | 510(k) clearance | Sep 25, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Shenzhen
Sources and methodology
- Original FDA record: K261585
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


